Since the official ending of the public health emergency in May 2023, Abbott has been experiencing a continuous decline in ...
Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average of ...
Since the official ending of the public health emergency in May 2023, Abbott has been experiencing a continuous decline in COVID testing-related demand. In Rapid Diagnostics, sales decreased 3% ...